Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Proteinea
AddedFeb 16, 2024
UpdatedJun 24, 2026
Proteinea

Proteinea

Seed

Proteinea: An Egypt/US-based biotech startup revolutionizing bio-manufacturing with insect-based platforms.

HQ
Newton, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
News
Website

Proteinea is an Egypt/US-based biotechnology startup focused on revolutionizing bio-manufacturing through insect-based platforms. The company leverages proprietary AI models and computational tools to design next-generation antibody medicines with enhanced efficacy, safety, and convenience. By replacing single-cell technologies with their innovative insect-based production platform, Proteinea aims to create smarter, faster, and safer protein engineering solutions for the biotech industry.

Proteinea has made significant strides in the field of biologics design, utilizing diverse learning objectives to overcome computational biases and explore novel therapeutic hits. Their AI-enabled approach has positioned them at the forefront of antibody engineering, contributing to advancements in medical treatments. The company's impact is evident in its pioneering methodologies and commitment to improving the landscape of bio-manufacturing and biologics.

Proteinea - Similar Companies

AI Proteins logo

AI Proteins

aiproteinstx.com

Nabla Bio logo

Nabla Bio

nabla.bio

Future Fields logo

Future Fields

futurefields.io

Profluent Bio logo

Profluent Bio

profluent.bio

Protillion Biosciences logo

Protillion Biosciences

protillion.com

Protein Dynamic Solutions logo

Protein Dynamic Solutions

pdsbio.com

BioLoomics logo

BioLoomics

bioloomics.com

BigHat Biosciences logo

BigHat Biosciences

bighatbio.com

Abterra Biosciences logo

Abterra Biosciences

abterrabio.com

iBio logo

iBio

ibioinc.com

Global Bio logo

Global Bio

20n logo

20n

LiliumX logo

LiliumX

liliumx.com

Liberation Labs logo

Liberation Labs

liberationlabs.com

Infinimmune logo

Infinimmune

infinimmune.com

Proteinea - Quick Facts

Who are Proteinea's competitors?

Companies similar to Proteinea include AI Proteins, Nabla Bio, Future Fields and Profluent Bio.

When was Proteinea founded?

Proteinea was founded in 2020.

Where is Proteinea's headquarters located?

Proteinea's headquarters is located in Newton, MA, US.

How much has Proteinea raised to-date?

As of Mar 1, 2023, Proteinea has raised a total of $2.8M (USD).

How many employees does Proteinea have?

Proteinea has 58 employees as of Feb 4, 2024.

Proteinea - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Antibody Medicines
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software